NCT03353545
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Ag.Andreas General Hospital Pátrai, Greece
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
NCT01255670
- Conditions
- Abscess, Disease Attributes, Infections, +12 more
- Locations
-
- Helsinki University Central Hospital Helsinki, Finland
NCT03209622
- Conditions
- Acute Coronary Syndrome, Behavior, Cardiovascular Diseases, +10 more
- Locations
-
- Abroug Monastir, Tunisia
NCT00981708
- Conditions
- Amyloidosis, Disease Attributes, Immune System Diseases, +13 more
- Locations
-
- Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece
NCT02187133
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of California, Davis Davis, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
NCT02307617
- Conditions
- Behavior, Behavioral Symptoms, Depression, +11 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01177735
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States
NCT00536601
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT04850131
- Conditions
- Disease Attributes, Neurologic Manifestations, Pain, +8 more
- Locations
-
- Benazir Bhutto Hospital Rawalpindi Rawalpindi, Punjab Province, Pakistan
Completed
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
NCT01990534
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Prague, Czechia
- Brno, Czechia
- Heidelberg, Baden-Wurttemberg, Germany
- Cologne, Germany